Developing prognostic biomarkers in intermediate age‐related macular degeneration: their clinical use in predicting progression

REFERENCES

• Wong WL, Su X, Li X et al. Global prevalence of age‐related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta‐analysis. Lancet Glob Health 2014; 2: e106–116.
   PubMed Web of Science ®Google Scholar
• Ferris FL, 3rd, Wilkinson CP, Bird A et al. Clinical classification of age‐related macular degeneration. Ophthalmology 2013; 120: 844–851.
   PubMed Web of Science ®Google Scholar
• Ferris FL, Davis MD, Clemons TE et al. A simplified severity scale for age‐related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 2005; 123: 1570–1574.
   PubMed Web of Science ®Google Scholar
• RANZCO. RANZCO Referral Pathway for AMD Screening and Management by Optometrists. 2016. [cited 2017 Jan 30]. Available from: https://ranzco.edu/ophthalmology-and-eye-health/collaborative-care/referral-pathway-for-amd-management
   Google Scholar
• Nivison‐smith L, Milston R, Madigan M, Kalloniatis M. Age‐related macular degeneration: linking clinical presentation to pathology. Optom Vis Sci 2014; 91: 832–848.
   PubMed Web of Science ®Google Scholar
• Ly A, Nivison‐smith L, Assaad N, Kalloniatis M. Fundus autofluorescence in age‐related macular degeneration. Optom Vis Sci 2017; 94: 246–259.
   Web of Science ®Google Scholar
• Ly A, Nivison‐smith L, Assaad N, Kalloniatis M. Infrared reflectance imaging in age‐related macular degeneration. Ophthalmic Physiol Opt 2016; 36: 303–316.
   Web of Science ®Google Scholar
• American Optometric Association Consensus Panel on Care of the Patient with Age‐Related Macular Degeneration. Optometric Clinical Practice Guideline. Care of the Patient with Age‐Related Macular Degeneration. St Louis, MO; 2004. [cited 30 Jan. 2017]. Available from: http://www.aoa.org/documents/optometrists/CPG-6.pdf
   Google Scholar
• The Royal College of Ophthalmologists. Age‐Related Macular Degeneration: Guidelines for Management. London; 2013. [cited 30 Jan. 2017]. Available from: https://www.rcophth.ac.uk/wp-content/uploads/2014/12/2013-SCI-318-RCOphth-AMD-Guidelines-Sept-2013-FINAL-2.pdf
   Google Scholar
• American Academy of Ophthalmology Retina/Vitreous Panel. Prefererd Practice Pattern^® Guidelines. Age‐Related Macular Degeneration. San Francisco, CA; 2015. [cited 30 Jan. 2017]. Available from: http://www.aao.org/Assets/db935a77‐1997‐4d60‐b850‐71b7602f46e2/635582143853270000/age‐related‐macular‐degeneration‐ppp‐pdf
   Google Scholar
• Canadian Journal of Optometry. Guidelines for the Collaborative Management of Persons with Age‐Related Macular Degeneration by Health‐ and Eye‐Care Professionals. Ottawa, Canada; 2015. [cited 30 Jan. 2017]. Available from: https://opto.ca/sites/default/files/resources/documents/cjo_journal_online_ehco_guidelines_eng_v2.pdf
   Google Scholar
• De sisternes L, Simon N, Tibshirani R, Leng T, Rubin DL. Quantitative SD‐OCT imaging biomarkers as indicators of age‐related macular degeneration progression. Invest Ophthalmol Vis Sci 2014; 55: 7093–7103.
   PubMed Web of Science ®Google Scholar
• Nathoo NA, Or C, Young M et al. Optical coherence tomography‐based measurement of drusen load predicts development of advanced age‐related macular degeneration. Am J Ophthalmol 2014; 158: 757–761.e1.
   Web of Science ®Google Scholar
• Abdelfattah NS, Zhang H, Boyer DS et al. Drusen Volume as a Predictor of Disease Progression in Patients With Late Age‐Related Macular Degeneration in the Fellow Eye. Invest Ophthalmol Vis Sci 2016; 57: 1839–1846.
   Web of Science ®Google Scholar
• Balaratnasingam C, Yannuzzi LA, Curcio CA et al. Associations Between Retinal Pigment Epithelium and Drusen Volume Changes During the Lifecycle of Large Drusenoid Pigment Epithelial Detachments. Invest Ophthalmol Vis Sci 2016; 57: 5479–5489.
   Web of Science ®Google Scholar
• Folgar FA, Yuan EL, Sevilla MB et al. Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2‐Year Progression of Age‐Related Macular Degeneration. Ophthalmology 2016; 123: 39–50.e1.
   Web of Science ®Google Scholar
• Schaal KB, Rosenfeld PJ, Gregori G, Yehoshua Z, Feuer WJ. Anatomic Clinical Trial Endpoints for Nonexudative Age‐Related Macular Degeneration. Ophthalmology 2016; 123: 1060–1079.
   Web of Science ®Google Scholar
• Seddon JM, Reynolds R, Yu Y, Rosner B. Validation of a prediction algorithm for progression to advanced macular degeneration subtypes. JAMA Ophthalmol 2013; 131: 448–455.
   PubMed Web of Science ®Google Scholar
• Klein ML, Ferris FL, 3rd, Armstrong J et al. Retinal precursors and the development of geographic atrophy in age‐related macular degeneration. Ophthalmology 2008; 115: 1026–1031.
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Wong TY, Fletcher A et al. Clinical risk factors for age‐related macular degeneration: a systematic review and meta‐analysis. BMC Ophthalmol 2010; 10: 31.
   PubMed Web of Science ®Google Scholar
• Silva R, Cachulo ML, Fonseca P et al. Age‐related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3‐year follow‐up study. Ophthalmologica 2011; 226: 110–118.
   Web of Science ®Google Scholar
• Lambert NG, Elshelmani H, Singh MK et al. Risk factors and biomarkers of age‐related macular degeneration. Prog Retin Eye Res 2016; 54: 64–102.
   PubMed Web of Science ®Google Scholar
• Virgili G, Michelessi M, Parodi MB, Bacherini D, Evans JR. Laser treatment of drusen to prevent progression to advanced age‐related macular degeneration. Cochrane Database Syst Rev 2015: CD006537.
   Web of Science ®Google Scholar
• Schuman SG, Koreishi AF, Farsiu S, Jung SH, Izatt JA, Toth CA. Photoreceptor layer thinning over drusen in eyes with age‐related macular degeneration imaged in vivo with spectral‐domain optical coherence tomography. Ophthalmology 2009; 116: 488–496.e2.
   PubMed Web of Science ®Google Scholar
• Michalewski J, Nawrocki J, Trebinska M, Michalewska Z. Spectral‐domain optical coherence tomography features preceding new‐onset neovascular membrane formation. Can J Ophthalmol 2014; 49: 339–344.
   PubMed Web of Science ®Google Scholar
• Yehoshua Z, Wang F, Rosenfeld PJ, Penha FM, Feuer WJ, Gregori G. Natural history of drusen morphology in age‐related macular degeneration using spectral domain optical coherence tomography. Ophthalmology 2011; 118: 2434–2441.
   Web of Science ®Google Scholar
• Schlanitz FG, Baumann B, Kundi M et al. Drusen volume development over time and its relevance to the course of age‐related macular degeneration. Br J Ophthalmol 2017; 101: 198–203.
   Web of Science ®Google Scholar
• Wu Z, Luu CD, Ayton LN et al. Optical coherence tomography‐defined changes preceding the development of drusen‐associated atrophy in age‐related macular degeneration. Ophthalmology 2014; 121: 2415–2422.
   PubMed Web of Science ®Google Scholar
• Sadigh S, Cideciyan AV, Sumaroka A et al. Abnormal thickening as well as thinning of the photoreceptor layer in intermediate age‐related macular degeneration. Invest Ophthalmol Vis Sci 2013; 54: 1603–1612.
   PubMed Web of Science ®Google Scholar
• Giocanti‐auregan A, Tadayoni R, Fajnkuchen F, Dourmad P, Magazzeni S, Cohen SY. Predictive value of outer retina en face OCT imaging for geographic atrophy progression. Invest Ophthalmol Vis Sci 2015; 56: 8325–8330.
   Web of Science ®Google Scholar
• Pieroni CG, Witkin AJ, Ko TH et al. Ultrahigh resolution optical coherence tomography in non‐exudative age related macular degeneration. Br J Ophthalmol 2006; 90: 191–197.
   PubMed Web of Science ®Google Scholar
• Fragiotta S, Carnevale C, Cutini A, Vingolo EM. Correlation between retinal function and microstructural foveal changes in intermediate age related macular degeneration. Int J Retina Vitreous 2017; 3: 8.
   Google Scholar
• Querques L, Querques G, Forte R, Souied EH. Microperimetric correlations of autofluorescence and optical coherence tomography imaging in dry age‐related macular degeneration. Am J Ophthalmol 2012; 153: 1110–1115.
   Web of Science ®Google Scholar
• Wu Z, Ayton LN, Luu CD, Guymer RH. Relationship between retinal microstructures on optical coherence tomography and microperimetry in age‐related macular degeneration. Ophthalmology 2014; 121: 1445–1452.
   Web of Science ®Google Scholar
• Toy BC, Krishnadev N, Indaram M et al. Drusen regression is associated with local changes in fundus autofluorescence in intermediate age‐related macular degeneration. Am J Ophthalmol 2013; 156: 532–542.e1.
   Web of Science ®Google Scholar
• Sarks SH. Drusen patterns predisposing to geographic atrophy of the retinal pigment epithelium. Aust J Ophthalmol 1982; 10: 91–97.
   Google Scholar
• Folgar FA, Chow JH, Farsiu S et al. Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD. Invest Ophthalmol Vis Sci 2012; 53: 4626–4633.
   Web of Science ®Google Scholar
• Christenbury JG, Folgar FA, O'connell RV, Chiu SJ, Farsiu S, Toth CA. Progression of intermediate age‐related macular degeneration with proliferation and inner retinal migration of hyperreflective foci. Ophthalmology 2013; 120: 1038–1045.
   PubMed Web of Science ®Google Scholar
• Leuschen JN, Schuman SG, Winter KP et al. Spectral‐domain optical coherence tomography characteristics of intermediate age‐related macular degeneration. Ophthalmology 2013; 120: 140–150.
   PubMed Web of Science ®Google Scholar
• Smith RT, Sohrab MA, Busuioc M, Barile G. Reticular macular disease. Am J Ophthalmol 2009; 148: 733–743.e2.
   PubMed Web of Science ®Google Scholar
• Zweifel SA, Imamura Y, Spaide TC, Fujiwara T, Spaide RF. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age‐related macular degeneration. Ophthalmology 2010; 117: 1775–1781.
   PubMed Web of Science ®Google Scholar
• Finger RP, Wu Z, Luu CD et al. Reticular pseudodrusen: A risk factor for geographic atrophy in fellow eyes of individuals with unilateral choroidal neovascularization. Ophthalmology 2014; 121: 1252–1256.
   Web of Science ®Google Scholar
• Zhou Q, Daniel E, Maguire MG et al. Pseudodrusen and incidence of late age‐related macular degeneration in fellow eyes in the Comparison of Age‐Related Macular Degeneration Treatments Trials. Ophthalmology 2016; 123: 1530–1540.
   Web of Science ®Google Scholar
• Spaide RF, Curcio CA. Drusen characterization with multimodal imaging. Retina 2010; 30: 1441–1454.
   PubMed Web of Science ®Google Scholar
• Zweifel SA, Spaide RF, Curcio CA, Malek G, Imamura Y. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 2010; 117: 303–312.e1.
   PubMed Web of Science ®Google Scholar
• Wu Z, Ayton LN, Luu CD, Baird PN, Guymer RH. Reticular pseudodrusen in intermediate age‐related macular degeneration: Prevalence, detection, clinical, environmental, and genetic associations. Invest Ophthalmol Vis Sci 2016; 57: 1310–1316.
   Web of Science ®Google Scholar
• Ooto S, Ellabban AA, Ueda‐arakawa N et al. Reduction of retinal sensitivity in eyes with reticular pseudodrusen. Am J Ophthalmol 2013; 156: 1184–1191.e2.
   Web of Science ®Google Scholar
• Steinberg JS, Fitzke FW, Fimmers R, Fleckenstein M, Holz FG, Schmitz‐valckenberg S. Scotopic and photopic microperimetry in patients with reticular drusen and age‐related macular degeneration. JAMA Ophthalmol 2015; 133: 690–697.
   PubMed Web of Science ®Google Scholar
• Neely D, Zarubina AV, Clark ME et al. Association between visual function and subretinal drusenoid deposits in normal and early age‐related macular degeneration eyes. Retina 2017; 37: 1329–1336.
   Web of Science ®Google Scholar
• Curcio CA, Messinger JD, Sloan KR, Mcgwin G, Medeiros NE, Spaide RF. Subretinal drusenoid deposits in non‐neovascular age‐related macular degeneration: morphology, prevalence, topography, and biogenesis model. Retina 2013; 33: 265–276.
   PubMed Web of Science ®Google Scholar
• Joachim N, Mitchell P, Rochtchina E, Tan AG, Wang JJ. Incidence and progression of reticular drusen in age‐related macular degeneration: findings from an older Australian cohort. Ophthalmology 2014; 121: 917–925.
   Web of Science ®Google Scholar
• Wu Z, Luu CD, Ayton LN et al. Fundus autofluorescence characteristics of nascent geographic atrophy in age‐related macular degeneration. Invest Ophthalmol Vis Sci 2015; 56: 1546–1552.
   Web of Science ®Google Scholar
• Bird AC, Bressler NM, Bressler SB et al. An international classification and grading system for age‐related maculopathy and age‐related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367–374.
   PubMed Web of Science ®Google Scholar
• Wu Z, Ayton LN, Luu CD, Guymer RH. Microperimetry of nascent geographic atrophy in age‐related macular degeneration. Invest Ophthalmol Vis Sci 2014; 56: 115–121.
   Web of Science ®Google Scholar
• Padnick‐silver L, Weinberg AB, Lafranco FP, Macsai MS. Pilot study for the detection of early exudative age‐related macular degeneration with optical coherence tomography. Retina 2012; 32: 1045–1056.
   Web of Science ®Google Scholar
• Sikorski BL, Bukowska D, Kaluzny JJ, Szkulmowski M, Kowalczyk A, Wojtkowski M. Drusen with accompanying fluid underneath the sensory retina. Ophthalmology 2011; 118: 82–92.
   Web of Science ®Google Scholar
• Batioglu F, Demirel S, Ozmert E, Oguz YG, Ozyol P. Autofluorescence patterns as a predictive factor for neovascularization. Optom Vis Sci 2014; 91: 950–955.
   Web of Science ®Google Scholar
• Cachulo L, Silva R, Fonseca P et al. Early markers of choroidal neovascularization in the fellow eye of patients with unilateral exudative age‐related macular degeneration. Ophthalmologica 2011; 225: 144–149.
   Web of Science ®Google Scholar
• Bindewald A, Bird AC, Dandekar SS et al. Classification of fundus autofluorescence patterns in early age‐related macular disease. Invest Ophthalmol Vis Sci 2005; 46: 3309–3314.
   Web of Science ®Google Scholar
• Midena E, Vujosevic S, Convento E, Manfre A, Cavarzeran F, Pilotto E. Microperimetry and fundus autofluorescence in patients with early age‐related macular degeneration. Br J Ophthalmol 2007; 91: 1499–1503.
   PubMed Web of Science ®Google Scholar
• Khanifar AA, Koreishi AF, Izatt JA, Toth CA. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age‐related macular degeneration. Ophthalmology 2008; 115: 1883–1890.
   PubMed Web of Science ®Google Scholar
• Veerappan M, El‐hage‐sleiman A‐KM, Tai V et al. Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age‐related Macular Degeneration. Ophthalmology 2016; 123: 2554–2570.
   Web of Science ®Google Scholar
• Rasmussen A, Brandi S, Fuchs J et al. Visual outcomes in relation to time to treatment in neovascular age‐related macular degeneration. Acta Ophthalmol 2015; 93: 616–620.
   PubMed Web of Science ®Google Scholar
• Chiu CJ, Mitchell P, Klein R et al. A risk score for the prediction of advanced age‐related macular degeneration: development and validation in 2 prospective cohorts. Ophthalmology 2014; 121: 1421–1427.
   PubMed Web of Science ®Google Scholar
• Damen JA, Hooft L, Schuit E et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ 2016; 353: i2416.
   PubMed Web of Science ®Google Scholar
• Kianoush S, Al rifai M, Cainzos‐achirica M et al. An update on the utility of coronary artery calcium scoring for coronary heart disease and cardiovascular disease risk prediction. Curr Atheroscler Rep 2016; 18: 13.
   PubMed Web of Science ®Google Scholar
• Bell K, Hayen A, Mcgeechan K, Neal B, Irwig L. Effects of additional blood pressure and lipid measurements on the prediction of cardiovascular risk. Eur J Prev Cardiol 2012; 19: 1474–1485.
   PubMed Web of Science ®Google Scholar
• Faria BM, Duman F, Zheng CX et al. Evaluating contrast sensitivity in age‐related macular degeneration using a novel computer‐based test, the Spaeth/Richman Contrast Sensitivity Test. Retina 2015; 35: 1465–1473.
   Web of Science ®Google Scholar
• Downie LE, Cheng AS, Vingrys AJ. Color vision deficits in intermediate age‐related macular degeneration. Optom Vis Sci 2014; 91: 932–938.
   Web of Science ®Google Scholar
• Wong EN, Chew AL, Morgan WH, Patel PJ, Chen FK. The use of microperimetry to detect functional progression in non‐neovascular age‐related macular degeneration: A systematic review. Asia Pac J Ophthalmol (Phila) 2017; 6: 70–79.
   PubMed Web of Science ®Google Scholar
• Moschos MM, Nitoda E. The role of mf‐ERG in the diagnosis and treatment of age‐related macular degeneration: Electrophysiological features of AMD. Semin Ophthalmol 2017: 1–9.
   Web of Science ®Google Scholar
• Owsley C, Mcgwin G, Jr., Clark ME et al. Delayed rod‐mediated dark adaptation is a functional biomarker for incident early age‐related macular degeneration. Ophthalmology 2016; 123: 344–351.
   PubMed Web of Science ®Google Scholar
• Dimitrov PN, Robman LD, Varsamidis M et al. Visual function tests as potential biomarkers in age‐related macular degeneration. Invest Ophthalmol Vis Sci 2011; 52: 9457–9469.
   PubMed Web of Science ®Google Scholar
• Dimitrov PN, Guymer RH, Zele AJ, Anderson AJ, Vingrys AJ. Measuring rod and cone dynamics in age‐related maculopathy. Invest Ophthalmol Vis Sci 2008; 49: 55–65.
   PubMed Web of Science ®Google Scholar
• Brown B, Adams AJ, Coletta NJ, Haegerstrom‐portnoy G. Dark adaptation in age‐related maculopathy. Ophthalmic Physiol Opt 1986; 6: 81–84.
   PubMed Web of Science ®Google Scholar
• Patel PJ, Chen FK, Rubin GS, Tufail A. Intersession repeatability of visual acuity scores in age‐related macular degeneration. Invest Ophthalmol Vis Sci 2008; 49: 4347–4352.
   PubMed Web of Science ®Google Scholar
• Lovie‐kitchin J, Feigl B. Assessment of age‐related maculopathy using subjective vision tests. Clin Exp Optom 2005; 88: 292–303.
   PubMedGoogle Scholar
• Puell MC, Barrio AR, Palomo‐alvarez C, Gomez‐sanz FJ, Clement‐corral A, Perez‐carrasco MJ. Impaired mesopic visual acuity in eyes with early age‐related macular degeneration. Invest Ophthalmol Vis Sci 2012; 53: 7310–7314.
   Web of Science ®Google Scholar
• Wu Z, Ayton LN, Guymer RH, Luu CD. Low‐luminance visual acuity and microperimetry in age‐related macular degeneration. Ophthalmology 2014; 121: 1612–1619.
   Web of Science ®Google Scholar
• Schneck ME, Haegerstrom‐portnoy G, Lott LA, Brabyn JA, Gildengorin G. Low contrast vision function predicts subsequent acuity loss in an aged population: the SKI study. Vision Res 2004; 44: 2317–2325.
   PubMed Web of Science ®Google Scholar
• Qiu F, Leat SJ. Functional deficits in early stage age‐related maculopathy. Clin Exp Optom 2009; 92: 90–98.
   Web of Science ®Google Scholar
• Lovie‐kitchin JE, Bowers AR, Woods RL. Oral and silent reading performance with macular degeneration. Ophthalmic Physiol Opt 2000; 20: 360–370.
   PubMed Web of Science ®Google Scholar
• Wu Z, Ayton LN, Luu CD, Guymer RH. Longitudinal changes in microperimetry and low luminance visual acuity in age‐related macular degeneration. JAMA Ophthalmol 2015; 133: 442–448.
   Web of Science ®Google Scholar
• Owsley C, Huisingh C, Clark ME, Jackson GR, Mcgwin G Jr. Comparison of visual function in older eyes in the earliest stages of age‐related macular degeneration to those in normal macular health. Curr Eye Res 2016; 41: 266–272.
   PubMed Web of Science ®Google Scholar
• Kalloniatis M, Harwerth RS. Modelling sensitivity losses in ocular disorders: colour vision anomalies following intense blue‐light exposure in monkeys. Ophthalmic Physiol Opt 1993; 13: 155–167.
   Web of Science ®Google Scholar
• Pianta MJ, Kalloniatis M. Characterisation of dark adaptation in human cone pathways: an application of the equivalent background hypothesis. J Physiol 2000; 528: 591–608.
   Web of Science ®Google Scholar
• Choi A, Nivison‐smith L, Khuu SK, Kalloniatis M. Spatial summation across the 10‐2 visual field in normal and age‐related macular degeneration. Proceedings of the ARVO Conference; Seattle; 2016 May 1–5; Seattle, Washington, USA.
   Google Scholar
• Cassels NK, Wild JM, Margrain TH, Chong V, Acton JH. The use of microperimetry in assessing visual function in age‐related macular degeneration. Surv Ophthalmol 2017; https://doi.org/10.1016/j.survophthal.2017.05.007.
   Web of Science ®Google Scholar
• Parisi V, Perillo L, Tedeschi M et al. Macular function in eyes with early age‐related macular degeneration with or without contralateral late age‐related macular degeneration. Retina 2007; 27: 879–890.
   Web of Science ®Google Scholar
• Liu L, Wang YZ, Bedell HE. Visual‐function tests for self‐monitoring of age‐related macular degeneration. Optom Vis Sci 2014; 91: 956–965.
   Web of Science ®Google Scholar
• Wu Z, Guymer RH, Finger RP. Low luminance deficit and night vision symptoms in intermediate age‐related macular degeneration. Br J Ophthalmol 2016; 100: 395–398.
   PubMed Web of Science ®Google Scholar
• Hogg RE, Chakravarthy U. Visual function and dysfunction in early and late age‐related maculopathy. Prog Retin Eye Res 2006; 25: 249–276.
   PubMed Web of Science ®Google Scholar
• Neelam K, Nolan J, Chakravarthy U, Beatty S. Psychophysical function in age‐related maculopathy. Surv Ophthalmol 2009; 54: 167–210.
   PubMed Web of Science ®Google Scholar
• Midena E, Pilotto E. Microperimetry in age: related macular degeneration. Eye (Lond) 2017; 31: 985–994.
   PubMed Web of Science ®Google Scholar
• Yehoshua Z, Rosenfeld PJ. Strategies for following dry age‐related macular degeneration. Ophthalmic Res 2012; 48 Suppl.1: 6–10.
   Web of Science ®Google Scholar